CapsoVision, Inc Foreign Currency Transaction Gain (Loss), Unrealized
CapsoVision, Inc (CV) reported Foreign Currency Transaction Gain (Loss), Unrealized of -$15.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ForeignCurrencyTransactionGainLossUnrealized · last filed 2026-08-13
- CapsoVision, Inc foreign currency transaction gain (loss), unrealized for the quarter ending 2026-06-30 was -$19.00K, a 113.01% decline year-over-year.
- CapsoVision, Inc foreign currency transaction gain (loss), unrealized for the quarter ending 2026-03-31 was $4.00K, a 66.67% decline year-over-year.
- CapsoVision, Inc foreign currency transaction gain (loss), unrealized for the quarter ending 2025-12-31 was $3.00K.
- CapsoVision, Inc foreign currency transaction gain (loss), unrealized for the quarter ending 2025-09-30 was $12.00K, a 60.00% decline year-over-year.
- CapsoVision, Inc foreign currency transaction gain (loss), unrealized for fiscal 2025 was $173.00K.
- CapsoVision, Inc foreign currency transaction gain (loss), unrealized for fiscal 2024 was -$103.00K.
| Period end | Foreign Currency Transaction Gain (Loss), Unrealized 3 month | Foreign Currency Transaction Gain (Loss), Unrealized 6 month | Foreign Currency Transaction Gain (Loss), Unrealized 9 month | Foreign Currency Transaction Gain (Loss), Unrealized 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$19.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$15.00K 10-Q · filed 2026-08-13 | -$12.00K derived: sum of 3 quarters · filed 2026-08-13 | $0.00 derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $4.00K 10-Q · filed 2026-05-14 | $7.00K derived: sum of 2 quarters · filed 2026-05-14 | $19.00K derived: sum of 3 quarters · filed 2026-05-14 | $165.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | $15.00K derived: sum of 2 quarters · filed 2026-03-26 | $161.00K derived: sum of 3 quarters · filed 2026-08-13 | $173.00K 10-K · filed 2026-03-26 |
| 2025-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $158.00K derived: sum of 2 quarters · filed 2026-08-13 | $170.00K 10-Q · filed 2025-11-13 | $49.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $146.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $158.00K 10-Q · filed 2026-08-13 | $37.00K derived: sum of 3 quarters · filed 2026-08-13 | $67.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $12.00K 10-Q · filed 2026-05-14 | -$109.00K derived: sum of 2 quarters · filed 2026-05-14 | -$79.00K derived: sum of 3 quarters · filed 2026-05-14 | |
| 2024-12-31 | -$121.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-26 | -$91.00K derived: sum of 2 quarters · filed 2026-03-26 | -$103.00K 10-K · filed 2026-03-26 | |
| 2024-09-30 | $30.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $18.00K 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | -$12.00K 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B |